Stockreport

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1 [TheStreet.com]

Telomir Pharmaceuticals, Inc.  (TELO) 
PDF New Drug application to the FDA for Telomir-1 (Telomir-Zn) targeting advanced and metastatic triple-negative breast cancer, supported by preclinical efficacy and safety [Read more]